Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
High-dose dexamethasone for postoperative pain after transoral robotic surgery
2019-004610-34Phase 3Completed
- Sponsor
- Rigshospitalet
- Start
- Mar 2020
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial in postoperative pain, squamous cell carcinoma of unknown primary (SCCUP) and obstructive sleep apnea hypopnea syndrome (OSAHS) comparing High-dose dexamethasone with Placebo / standard care control (2 arms). Primary endpoints: Postoperative pain intensity at rest and Postoperative pain intensity during swallowing. Started Mar 2020; status: completed.
02
Drugs
dexamethasone
03
Conditions
postoperative painsquamous cell carcinoma of unknown primary (SCCUP)obstructive sleep apnea hypopnea syndrome (OSAHS)
Beyond the preview
Go deeper on 2019-004610-34.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2019-004610-34.